{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:32:53Z","timestamp":1791261173411,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CD23\/00010"],"award-info":[{"award-number":["CD23\/00010"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014419","name":"EIT Health","doi-asserted-by":"publisher","award":["220628\/230125"],"award-info":[{"award-number":["220628\/230125"]}],"id":[{"id":"10.13039\/100014419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014419","name":"EIT Health","doi-asserted-by":"publisher","award":["220628\/230125"],"award-info":[{"award-number":["220628\/230125"]}],"id":[{"id":"10.13039\/100014419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014419","name":"EIT Health","doi-asserted-by":"publisher","award":["220628\/230125"],"award-info":[{"award-number":["220628\/230125"]}],"id":[{"id":"10.13039\/100014419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014419","name":"EIT Health","doi-asserted-by":"publisher","award":["220628\/230125"],"award-info":[{"award-number":["220628\/230125"]}],"id":[{"id":"10.13039\/100014419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014419","name":"EIT Health","doi-asserted-by":"publisher","award":["220628\/230125"],"award-info":[{"award-number":["220628\/230125"]}],"id":[{"id":"10.13039\/100014419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014419","name":"EIT Health","doi-asserted-by":"publisher","award":["220628\/230125"],"award-info":[{"award-number":["220628\/230125"]}],"id":[{"id":"10.13039\/100014419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014419","name":"EIT Health","doi-asserted-by":"publisher","award":["220628\/230125"],"award-info":[{"award-number":["220628\/230125"]}],"id":[{"id":"10.13039\/100014419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014419","name":"EIT Health","doi-asserted-by":"publisher","award":["220628\/230125"],"award-info":[{"award-number":["220628\/230125"]}],"id":[{"id":"10.13039\/100014419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014419","name":"EIT Health","doi-asserted-by":"publisher","award":["220628\/230125"],"award-info":[{"award-number":["220628\/230125"]}],"id":[{"id":"10.13039\/100014419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014419","name":"EIT Health","doi-asserted-by":"publisher","award":["220628\/230125"],"award-info":[{"award-number":["220628\/230125"]}],"id":[{"id":"10.13039\/100014419","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Gen Psychiatry"],"DOI":"10.1186\/s12991-024-00544-8","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T17:55:46Z","timestamp":1738864546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["RNA editing-based biomarker blood test for the diagnosis of bipolar disorder: protocol of the EDIT-B study"],"prefix":"10.1186","volume":"24","author":[{"given":"Andrea","family":"Miranda-Mendizabal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zambrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Zarp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Chavarr\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gim\u00e9nez-Palomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meritxell","family":"Gonzalez-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Walczer Baldinazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Siddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinah","family":"Weissmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep Maria","family":"Haro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Vedel Kessing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"issue":"S1","key":"544_CR1","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/S0165-0327(14)70004-7","volume":"169","author":"RM Hirschfeld","year":"2014","unstructured":"Hirschfeld RM. Differential diagnosis of bipolar disorder and major depressive disorder. J Affect Disord. 2014;169(S1):S12\u20136.","journal-title":"J Affect Disord"},{"issue":"5","key":"544_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1176\/appi.ajp.2017.17090972","volume":"175","author":"E Vieta","year":"2018","unstructured":"Vieta E, Salagre E, Grande I, Carvalho AF, Fernandes BS, Berk M, et al. Early intervention in bipolar disorder. Am J Psychiatry. 2018;175(5):411\u201326.","journal-title":"Am J Psychiatry"},{"issue":"6","key":"544_CR3","doi-asserted-by":"publisher","first-page":"641","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_163_23","volume":"65","author":"S Bhardwaj","year":"2023","unstructured":"Bhardwaj S, Sinha D, Pawar A, Mane A. Predominant polarity in bipolar affective disorder and its impact on cognition and quality of life. Indian J Psychiatry. 2023;65(6):641\u20136.","journal-title":"Indian J Psychiatry"},{"key":"544_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40345-022-00261-9","volume":"10","author":"J Benacek","year":"2022","unstructured":"Benacek J, Martin-Key NA, Spadaro B, Tomasik J, Bahn S. Using decision-analysis modelling to estimate the economic impact of the identification of unrecognised bipolar disorder in primary care: the untapped potential of screening. Int J Bipolar Disord. 2022;10:15.","journal-title":"Int J Bipolar Disord"},{"issue":"3","key":"544_CR5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1017\/S0033291721002026","volume":"53","author":"KSO Sletved","year":"2023","unstructured":"Sletved KSO, Ziersen SC, Andersen PK, Vinberg M, Kessing LV. Socio-economic functioning in patients with bipolar disorder and their unaffected siblings\u2014results from a nation-wide population-based longitudinal study. Psychol Med. 2023;53(3):706\u201313.","journal-title":"Psychol Med"},{"issue":"3","key":"544_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jad.2004.11.001","volume":"85","author":"LV Kessing","year":"2005","unstructured":"Kessing LV. Diagnostic stability in bipolar disorder in clinical practise as according to ICD-10. J Affect Disord. 2005;85(3):293\u20139.","journal-title":"J Affect Disord"},{"issue":"5","key":"544_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/bdi.12499","volume":"19","author":"K Fritz","year":"2017","unstructured":"Fritz K, Russell AMT, Allwang C, Kuiper S, Lampe L, Malhi GS. Is a delay in the diagnosis of bipolar disorder inevitable? Bipolar Disord. 2017;19(5):396\u2013400.","journal-title":"Bipolar Disord"},{"issue":"1\u20133","key":"544_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jad.2007.07.021","volume":"107","author":"AR Rosa","year":"2008","unstructured":"Rosa AR, Andreazza AC, Kunz M, Gomes F, Santin A, Sanchez-Moreno J, et al. Predominant polarity in bipolar disorder: diagnostic implications. J Affect Disord. 2008;107(1\u20133):45\u201351.","journal-title":"J Affect Disord"},{"issue":"9","key":"544_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.34078","volume":"6","author":"A Ratheesh","year":"2023","unstructured":"Ratheesh A, Hammond D, Watson M, Betts J, Siegel E, McGorry P, et al. Bipolar at-risk criteria and risk of bipolar disorder over 10 or more years. JAMA Netw Open. 2023;6(9): e2334078.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"544_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/acps.12667","volume":"135","author":"L Kessing","year":"2017","unstructured":"Kessing L, Andersen P. Evidence for clinical progression of unipolar and bipolar disorders. Acta Psychiatr Scand. 2017;135(1):51\u201364.","journal-title":"Acta Psychiatr Scand"},{"key":"544_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jad.2015.04.024","volume":"182","author":"AC Altamura","year":"2015","unstructured":"Altamura AC, Buoli M, Caldiroli A, Caron L, Cumerlato Melter C, Dobrea C, et al. Misdiagnosis, duration of untreated illness (DUI) and outcome in bipolar patients with psychotic symptoms: a naturalistic study. J Affect Disord. 2015;182:70\u20135.","journal-title":"J Affect Disord"},{"issue":"5","key":"544_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00406-009-0085-2","volume":"260","author":"AC Altamura","year":"2010","unstructured":"Altamura AC, Dell\u2019Osso B, Berlin HA, Buoli M, Bassetti R, Mundo E. Duration of untreated illness and suicide in bipolar disorder: a naturalistic study. Eur Arch Psychiatry Clin Neurosci. 2010;260(5):385\u201391.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"544_CR13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2147\/CEOR.S259338","volume":"12","author":"L Bessonova","year":"2020","unstructured":"Bessonova L, Ogden K, Doane MJ, O\u2019sullivan AK, Tohen M. The economic burden of bipolar disorder in the United States: a systematic literature review. Clinicecon Outcomes Res. 2020;12:481\u201397.","journal-title":"Clinicecon Outcomes Res"},{"issue":"2","key":"544_CR14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s12640-017-9835-5","volume":"33","author":"M Sowa-Ku\u0107ma","year":"2018","unstructured":"Sowa-Ku\u0107ma M, Stycze\u0144 K, Siwek M, Misztak P, Nowak RJ, Dudek D, et al. Lipid peroxidation and immune biomarkers are associated with major depression and its phenotypes, including treatment-resistant depression and melancholia. Neurotox Res. 2018;33(2):448\u201360.","journal-title":"Neurotox Res"},{"key":"544_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41398-024-02921-z","volume":"14","author":"S Poletti","year":"2024","unstructured":"Poletti S, Mazza MG, Benedetti F. Inflammatory mediators in major depression and bipolar disorder. Transl Psychiatry. 2024;14:247.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"544_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41392-023-01333-7","volume":"8","author":"YL Wu","year":"2023","unstructured":"Wu YL, Lin ZJ, Li CC, Lin X, Shan SK, Guo B, et al. Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. Signal Transduct Target Ther. 2023;8(1):98.","journal-title":"Signal Transduct Target Ther"},{"issue":"15","key":"544_CR17","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.2217\/epi-2021-0074","volume":"13","author":"HM Abdolmaleky","year":"2021","unstructured":"Abdolmaleky HM, Zhou JR, Thiagalingam S. Cataloging recent advances in epigenetic alterations in major mental disorders and autism. Epigenomics. 2021;13(15):1231\u201345.","journal-title":"Epigenomics"},{"issue":"3","key":"544_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2217\/epi.14.85","volume":"7","author":"HM Abdolmaleky","year":"2015","unstructured":"Abdolmaleky HM, Zhou J-R, Thiagalingam S. An update on the epigenetics of psychotic diseases and autism. Epigenomics. 2015;7(3):427\u201349.","journal-title":"Epigenomics"},{"issue":"8","key":"544_CR19","doi-asserted-by":"publisher","first-page":"e878","DOI":"10.1038\/tp.2016.121","volume":"6","author":"D Weissmann","year":"2016","unstructured":"Weissmann D, van der Laan S, Underwood MD, Salvetat N, Cavarec L, Vincent L, et al. Region-specific alterations of A-to-I RNA editing of serotonin 2c receptor in the cortex of suicides with major depression. Transl Psychiatry. 2016;6(8):e878\u20139.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"544_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41398-018-0331-3","volume":"9","author":"F Chimienti","year":"2019","unstructured":"Chimienti F, Cavarec L, Vincent L, Salvetat N, Arango V, Underwood MD, et al. Brain region-specific alterations of RNA editing in PDE8A mRNA in suicide decedents. Transl Psychiatry. 2019;9(1):91.","journal-title":"Transl Psychiatry"},{"issue":"12","key":"544_CR21","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1261\/rna.078804.121","volume":"27","author":"BRE Ansell","year":"2021","unstructured":"Ansell BRE, Thomas SN, Bonelli R, Munro JE, Freytag S, Bahlo M. A survey of RNA editing at single-cell resolution links interneurons to schizophrenia and autism. RNA. 2021;27(12):1482\u201396.","journal-title":"RNA"},{"key":"544_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.psychres.2023.115422","volume":"328","author":"MAF Hayashi","year":"2023","unstructured":"Hayashi MAF, Salvetat N, Cayzac C, Checa-Robles FJ, Dubuc B, Mereuze S, et al. Euthymic and depressed bipolar patients are characterized by different RNA editing patterns in blood. Psychiatry Res. 2023;328:3\u20136.","journal-title":"Psychiatry Res"},{"issue":"8","key":"544_CR23","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3390\/genes11080872","volume":"11","author":"A Barbon","year":"2020","unstructured":"Barbon A, Magri C. RNA editing and modifications in mood disorders. Genes. 2020;11(8):872.","journal-title":"Genes"},{"issue":"6","key":"544_CR24","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s13365-019-00772-9","volume":"25","author":"N Salvetat","year":"2019","unstructured":"Salvetat N, Van der Laan S, Vire B, Chimienti F, Cleophax S, Bronowicki JP, et al. RNA editing blood biomarkers for predicting mood alterations in HCV patients. J Neurovirol. 2019;25(6):825\u201336.","journal-title":"J Neurovirol"},{"key":"544_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jad.2024.04.022","volume":"356","author":"N Salvetat","year":"2024","unstructured":"Salvetat N, Checa-Robles FJ, Delacr\u00e9taz A, Cayzac C, Dubuc B, Vetter D, et al. AI algorithm combined with RNA editing-based blood biomarkers to discriminate bipolar from major depressive disorders in an external validation multicentric cohort. J Affect Disord. 2024;356:385\u201393.","journal-title":"J Affect Disord"},{"key":"544_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:1\u201342.","journal-title":"BMJ"},{"issue":"Suppl 20","key":"544_CR27","first-page":"22","volume":"59","author":"D Sheehan","year":"1998","unstructured":"Sheehan D, Lecrubier Y, Sheehan K, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22\u201333.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"544_CR28","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382\u20139.","journal-title":"Br J Psychiatry"},{"issue":"11","key":"544_CR29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133(11):429\u201335.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"544_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-022-01938-6","volume":"12","author":"N Salvetat","year":"2022","unstructured":"Salvetat N, Checa-Robles FJ, Patel V, Cayzac C, Dubuc B, Chimienti F, et al. A game changer for bipolar disorder diagnosis using RNA editing-based biomarkers. Transl Psychiatry. 2022;12(1):1\u201310.","journal-title":"Transl Psychiatry"},{"issue":"7","key":"544_CR31","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s11136-012-0322-4","volume":"22","author":"MF Janssen","year":"2013","unstructured":"Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22(7):1717\u201327.","journal-title":"Qual Life Res"},{"issue":"9","key":"544_CR32","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1553-2712.1996.tb03538.x","volume":"3","author":"NM Fenn Buderer","year":"1996","unstructured":"Fenn Buderer NM. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med. 1996;3(9):895\u2013900.","journal-title":"Acad Emerg Med"},{"issue":"5","key":"544_CR33","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1136\/emj.20.5.453","volume":"20","author":"SR Jones","year":"2003","unstructured":"Jones SR, Carley S, Harrison M. An introduction to power and sample size estimation. Emerg Med J. 2003;20(5):453\u20138.","journal-title":"Emerg Med J"},{"key":"544_CR34","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1259\/bjr.70.832.9166071","volume":"70","author":"NED Hawass","year":"1997","unstructured":"Hawass NED. Comparing the sensitivities and specificities of two diagnostic procedures performed on the same group of patients. Br J Radiol. 1997;70:360\u20136.","journal-title":"Br J Radiol"},{"key":"544_CR35","unstructured":"Bicego M, Mensi A. Null\/No Information Rate (NIR): a statistical test to assess if a classification accuracy is significant for a given problem. arXiv preprint arXiv:2306.06140. 2023."},{"key":"544_CR36","unstructured":"Paluszynska A, Biecek P, Jiang Y. Explaining and visualizing random forests in terms of variable importance. R package version 0.10.1. 2022. https:\/\/CRAN.R-project.org\/package=randomForestExplainer."},{"key":"544_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.euroneuro.2022.08.001","volume":"63","author":"P Fusar-Poli","year":"2022","unstructured":"Fusar-Poli P, Manchia M, Koutsouleris N, Leslie D, Woopen C, Calkins ME, et al. Ethical considerations for precision psychiatry: a roadmap for research and clinical practice. Eur Neuropsychopharmacol. 2022;63:17\u201334.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"544_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1176\/appi.ajp.2012.12091189","volume":"170","author":"R Freedman","year":"2013","unstructured":"Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA, et al. The initial field trials of DSM-5: new blooms and old thorns. Am J Psychiatry. 2013;170(1):1\u20135.","journal-title":"Am J Psychiatry"},{"key":"544_CR39","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1176\/appi.ajp.157.11.1873","volume":"157","author":"RMA Hirschfeld","year":"2000","unstructured":"Hirschfeld RMA, Williams JBW, Spitzer R, Calabrese J, Flynn L, Keck P, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157:1873\u20135.","journal-title":"Am J Psychiatry"},{"key":"544_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/548349","volume":"2013","author":"A Sasdelli","year":"2013","unstructured":"Sasdelli A, Lia L, Luciano CC, Nespeca C, Berardi D, Menchetti M. Screening for bipolar disorder symptoms in depressed primary care attenders: comparison between Mood Disorder Questionnaire and Hypomania Checklist (HCL-32). Psychiatry J. 2013;2013:1\u20139.","journal-title":"Psychiatry J"},{"issue":"2","key":"544_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0165-0327(03)00156-3","volume":"81","author":"CJ Miller","year":"2004","unstructured":"Miller CJ, Klugman J, Berv DA, Rosenquist KJ, Ghaemi SN. Sensitivity and specificity of the Mood Disorder Questionnaire for detecting bipolar disorder. J Affect Disord. 2004;81(2):167\u201371.","journal-title":"J Affect Disord"},{"issue":"3","key":"544_CR42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jad.2011.12.033","volume":"140","author":"IAT Le\u00e3o","year":"2012","unstructured":"Le\u00e3o IAT, Del Porto JA. Cross validation with the mood disorder questionnaire (MDQ) of an instrument for the detection of hypomania in Brazil: the 32 item hypomania symptom check-list, first revision (HCI-32-R1). J Affect Disord. 2012;140(3):215\u201321.","journal-title":"J Affect Disord"},{"issue":"Suppl 1","key":"544_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4088\/JCP.11096su1c.01","volume":"62","author":"RM Hirschfeld","year":"2001","unstructured":"Hirschfeld RM. Bipolar spectrum disorder: improving its recognition and diagnosis. J Clin Psychiatry. 2001;62(Suppl 1):5\u20139.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"544_CR44","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1001\/jamapsychiatry.2023.4096","volume":"81","author":"J Tomasik","year":"2024","unstructured":"Tomasik J, Harrison SJ, Rustogi N, Olmert T, Barton-Owen G, Han SYS, et al. Metabolomic biomarker signatures for bipolar and unipolar depression. JAMA Psychiat. 2024;81(1):101\u20136.","journal-title":"JAMA Psychiat"},{"key":"544_CR45","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jad.2022.03.080","volume":"308","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Wu X, Liu H, Niu Z, Zhao J, Wang F, et al. Employing biochemical biomarkers for building decision tree models to predict bipolar disorder from major depressive disorder. J Affect Disord. 2022;308:190\u20138.","journal-title":"J Affect Disord"},{"issue":"8","key":"544_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/brainsci10080564","volume":"10","author":"M Vismara","year":"2020","unstructured":"Vismara M, Girone N, Cirnigliaro G, Fasciana F, Vanzetto S, Ferrara L, et al. Peripheral biomarkers in DSM-5 anxiety disorders: an updated overview. Brain Sci. 2020;10(8):1\u201337.","journal-title":"Brain Sci"},{"issue":"6","key":"544_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015462","volume":"7","author":"LV Kessing","year":"2017","unstructured":"Kessing LV, Munkholm K, Faurholt-Jepsen M, Miskowiak KW, Nielsen LB, Frikke-Schmidt R, et al. The bipolar illness onset study: research protocol for the BIO cohort study. BMJ Open. 2017;7(6): e015462.","journal-title":"BMJ Open"},{"key":"544_CR48","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.euroneuro.2023.04.012","volume":"73","author":"L Samalin","year":"2023","unstructured":"Samalin L, Belzeaux R. Why does non-adherence to treatment remain a leading cause of relapse in patients with bipolar disorder? Eur Neuropsychopharmacol. 2023;73:16\u20138.","journal-title":"Eur Neuropsychopharmacol"},{"key":"544_CR49","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1741-7015-11-126","volume":"11","author":"BN Cuthbert","year":"2013","unstructured":"Cuthbert BN, Insel TR. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 2013;11:126.","journal-title":"BMC Med"},{"issue":"8","key":"544_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jpm13081245","volume":"13","author":"K Decker","year":"2023","unstructured":"Decker K, Murata S, Baig N, Hasan S, Halaris A. Utilizing the systemic immune-inflammation index and blood-based biomarkers in association with treatment responsiveness amongst patients with treatment-resistant bipolar depression. J Pers Med. 2023;13(8):1\u201323.","journal-title":"J Pers Med"},{"issue":"7","key":"544_CR51","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.tics.2019.03.009","volume":"23","author":"E Feczko","year":"2019","unstructured":"Feczko E, Miranda-Dominguez O, Marr M, Graham AM, Nigg JT, Fair DA. The heterogeneity problem: approaches to identify psychiatric subtypes. Trends Cogn Sci. 2019;23(7):584\u2013601.","journal-title":"Trends Cogn Sci"},{"key":"544_CR52","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.euroneuro.2023.04.018","volume":"74","author":"J-W Hsu","year":"2023","unstructured":"Hsu J-W, Chen L-C, Tsai S-J, Huang K-L, Bai Y-M, Su T-P, et al. Disease progression to bipolar disorder among adolescents and young adults with antidepressant-resistant and antidepressant-responsive depression: does antidepressant class matter? Eur Neuropsychopharmacol. 2023;74:22\u20139.","journal-title":"Eur Neuropsychopharmacol"},{"key":"544_CR53","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.euroneuro.2023.01.004","volume":"69","author":"A Fagiolini","year":"2023","unstructured":"Fagiolini A, Cuomo A. Treating major depressive disorder with mixed features. Eur Neuropsychopharmacol. 2023;69:58\u20139.","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["Annals of General Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12991-024-00544-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12991-024-00544-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12991-024-00544-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T18:19:49Z","timestamp":1738865989000},"score":1,"resource":{"primary":{"URL":"https:\/\/annals-general-psychiatry.biomedcentral.com\/articles\/10.1186\/s12991-024-00544-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["544"],"URL":"https:\/\/doi.org\/10.1186\/s12991-024-00544-8","relation":{},"ISSN":["1744-859X"],"issn-type":[{"value":"1744-859X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"assertion":[{"value":"15 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval has been obtained in France by the research ethics committee Ile-de-France X (ID 2021-A-03194-37), in Spain by the research ethics committees of the Hospital Clinic of Barcelona (ID HCB\/2022\/0042) and the Sant Joan de D\u00e9u Foundation (PS-05-22) and in Denmark by the De Videnskabsetiske Komiteer for Region Hovedstaden (the Scientific Ethics Committees for the Capital Region of Denmark) (ID H-22010899).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Alcediag is an innovative diagnostic company that focuses on mental health, developing and commercializing innovative in vitro diagnostic tests. Alcediag has developed the EDIT-B test, which is based on proprietary RNA editing biomarkers. DW is the CSO of Alcediag. EV has received grants and served as consultant, advisor or CME speaker for the following entities outside the submitted work: AB-Biotics, AbbVie, Adamed, Angelini, Biogen, Beckley-Psytech, Biohaven, Boehringer-Ingelheim, Celon Pharma, Compass, Dainippon Sumitomo Pharma, Ethypharm, Ferrer, Gedeon Richter, GH Research, Glaxo-Smith Kline, HMNC, Idorsia, Johnson & Johnson, Lundbeck, Luye Pharma, Medincell, Merck, Newron, Novartis, Orion Corporation, Organon, Otsuka, Roche, Rovi, Sage, Sanofi-Aventis, Sunovion, Takeda, Teva, and Viatris. AG-P has received CME-related honoraria or consulting fees from Janssen-Cilag, Lundbeck, Casen Recordati, the LCN, Rovi and Angelini, outside the submitted work. JZP has received honoraria from Lundbeck Pharma A\/S within the last three years, outside the submitted work. LVK has received\u00a0honoraria from Lundbeck Pharma and Teva within the last three years, outside the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}